Baseline Immune Activation as a Risk Factor for the Onset of Depression During Interferon-Alpha Treatment

Marieke Wichers; Günter Kenis; Carsten Leue; Ger H. Koek; Geert Robaeys; Michael Maes

doi:10.1016/j.biopsych.2005.11.024

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

Some interleukins, their receptors and alpha-1-acid glycoprotein as the indicators of immune activation in major depression

A. Służewska, J.K. Rybakowski, E. Bosmans, Michael Maes, Magdalena Sobieska

Article2020

16742 Depression as a risk factor for the development of psoriasis

Isabelle A. Vallerand, Ryan T. Lewinson, Laurie Parsons, Mark Lowerison, Scott Burton Patten, Cheryl Barnabé

Article2002

Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus

Stefania Bonaccorso, Valentina Marino, Massimo Biondi, Franca Grimaldi, Flora Ippoliti, Michael Maes

Article2018

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study

Isabelle A. Vallerand, Ryan T. Lewinson, Alexandra Frolkis, Mark Lowerison, Gilaad G. Kaplan, Mark G. Swain, Andrew G. M. Bulloch, Scott Burton Patten, Cheryl Barnabé

Article2001

Family history as a risk factor for early onset myocardial infarction in young women

Yechiel Friedlander, Patrick G. Arbogast, Stephen M. Schwartz, Santica M. Marcovina, Melissa A. Austin, Frits R. Rosendaal, Alexander P. Reiner, Bruce M. Psaty, David S. Siscovick

Atherosclerosis